Dr. Zeisel is the Kenan Distinguished University Professor in the Department of Nutrition in the Gillings School of Global Public Health and School of Medicine at the University of North Carolina at Chapel Hill. Dr. Zeisel earned his MD from Harvard Medical School in 1975, was a resident in pediatrics at Yale University from 1975–1977, and earned his PhD in nutrition at the Massachusetts Institute of Technology in 1980. He served as chair of the Department of Nutrition at UNC from 1990-2005.
Dr. Zeisel is the Director of the UNC Nutrition Research Institute and Director of the UNC Nutrition and Obesity Research Center (one of 12 centers of excellence funded by the US NIH), North Carolina. He serves on the Federation of American Societies for Experimental Biology (FASEB) Journal editorial board. His research team focuses on the essential nutrient choline and why there are individual differences in nutrient metabolism, using new approaches in nutrigenetics and metabolomics. Dr. Zeisel has proven that humans require choline and that this nutrient is critical for normal brain development, and for liver and muscle function. He is an international leader in the development of the field of precision nutrition. Based on his research, the US Institute of Medicine set a dietary requirement for choline in 1998. Dr. Zeisel has authored more than 350 scientific publications.
Executive Director and CEO of the Global Institute for Food Security at Saskatoon
Prior to joining the Global Institute for Food Security, Dr. Moloney led the work of over 1,100 research and support staff in R&D in Agriculture, Food and Nutrition and Biosecurity at Australia’s Commonwealth Scientific and Industrial Research Organization (CSIRO). Previously, Dr. Moloney was the Director and Chief Executive of the world’s oldest agriculture research centre, Rothamsted Research. The UK-based institute is a world leader in food security, agricultural sustainability and the adaptation of agriculture to the consequences of both climate change and fossil fuel depletion.
Founder of SemBioSys Genetics Inc. based in Calgary, Dr. Moloney also served as the company’s President from 1994-1998 and as Chief Scientific Officer from 1998-2010. He held a Dow AgroSciences-Natural Sciences and Engineering Research Council of Canada (NSERC) Industrial Research Chair in plant biotechnology from 1995 until 2003. Dr. Moloney also spent fifteen years as a professor in the Department of Biological Sciences at the University of Calgary pursuing research on seed-specific gene expression, herbicide resistance, recombinant protein production and the plant cell cycle. Previously, he was the head of the Cell Biology Group at Calgene Inc., where he developed the first transgenic oilseed plants using Canola as the target. This resulted in a landmark patent in plant biotechnology and eventually became the basis of RoundUp Ready® and Liberty Link® Canola, which now commands more than 90% of the Canola acreage in Canada with a seed market of more than $200 million per year and a product value of >$8 billion annually.
Dr. Moloney has published more than 90 original research papers and is an inventor on 43 issued US patents and over 300 patents worldwide. He was Chair and Co-organizer of the International Society for Plant Molecular Biology Congress in Quebec City, June 2000 and continues to serve on the conference’s board. He has served on the advisory board of the National Research Council of Canada’s Plant Biotechnology Institute and on numerous Canadian Federal government committees including NSERC Council (the governing body of NSERC), Canadian Foundation for Innovation (CFI), and the Networks of Centres of Excellence program. He has consulted for several biotechnology and multinational agribusiness companies. He has also worked extensively with the UK Government and the EU on issues relating to agricultural policy and biotechnology at the ministerial and commissioner levels. He has received a number of prestigious awards, including two Alberta Science and Technology (ASTECH) Awards for leadership in Alberta Technology. Dr. Moloney holds a Bachelor of Science degree in Chemistry from Imperial College, London, Associateship of the Royal College of Science, and was awarded his doctorate in plant biochemistry from De Montfort University/Leicester Polytechnic in the United Kingdom. He was honoured by the University of Lethbridge with a D.Sc. honoris causa in 2004 by De Montfort University in 2011 and by Lancaster University, U.K. in 2013.
Professor, Marketing; James McGill Chair of Consumer and Lifestyle Psychology and Marketing; Chair and Scientific Director, McGill Centre for the Convergence of Health and Economics – McGill University
Dr. Dubé is a Full Professor and holds the James McGill Chair of consumer and lifestyle psychology and marketing at the Desautels Faculty of Management of McGill University, Canada. Her research interest bears on the study of affects and behavioural economic processes underlying consumption and lifestyle behaviour and how such knowledge can inspire more effective health and marketing communications in both real-life and technology-supported media. She is the Founding Chair and Scientific Director of the McGill Centre for the Convergence of Health and Economics. The MCCHE was created to foster partnerships among scientists and decision-makers from all sectors of society to encourage a more ambitious notion of what can be done for more effective health management and novel pathways for social and business innovation.
Beyond books and scientific publications in the leading scientific journals of her field, including Journal of Consumer Research, Journal of Marketing Research, Journal of Marketing, Management Information System Quarterly and Journal of Personality and Social Psychology. Her transdiciplinary work has been presented in the Proceedings of the National Academy of Sciences and the Annals of the New York Academy of Sciences, her work has been covered in general audience and business publications such as Maclean’s, The Globe and Mail, USA Today, The Wall Street Journal, The Atlantic, and The Economist. Dr. Dubé received the YMCA Women of Distinction Award for the social sciences in 2011 and the Queen Elizabeth II Diamond Jubilee Medal in 2013. She is a Fellow of the Royal Society of Canada.
Dr. Robert Duncan is a canola and high erucic acid rapeseed breeder in the Department of Plant Science. Rob and his team develop new varieties that are grown by farmers across western Canada. His team focuses on developing high yielding, disease resistant varieties with excellent end use quality. End use quality includes the oil content, fatty acid profile, protein content and other protein-related traits. A major component of Rob’s research program is to increase the erucic acid content, which is used as a lubricant and slip agent and can be found in many household products (plastics and cosmetics) that are used on a daily basis. Rob’s team is also focused on characterizing the protein related-traits in Brassica species and determining the genetic control of these traits. Specific research goals include improving end use quality in these varieties in order to improve the extraction efficiency, as well as improving the agronomic traits so that farmers can grow their crop in a more economically and environmentally efficient manner.
Dr. Rempel is the Vice President, Crop Production and Innovation at Canola Council of Canada, and joined the Council in July 2012. He is responsible for directing the Crop Production team agronomists and staff with a mandate to optimize profitability for producers and the supply chains they serve while minimizing production risk; developing research priorities for canola production, oil and meal utilization; developing sustainability and production stewardship guidelines; liaising between producers, industry and academia to optimize extension activity; managing the coordination of the trials and budget for the Western Canada Canola/Rapeseed Recommending Committee and the Canola Performance Trials; monitoring and managing issues related to domestic and global biotechnology acceptance and regulation; and representing Canadian canola’s interests with industry and professional groups.
Dr. Rempel was raised on a farm specializing in dairy and special crops in Manitoba and is still involved with commercial farm production. He holds a B.Sc. and M.Sc. from the University of Manitoba, a PhD from the University of Guelph, and an MBA from Athabasca University/University of Guelph. Prior to joining the Council, Dr. Rempel has worked as a research scientist for Agriculture and Agri-food Canada; has taught at numerous universities and community colleges; and has operated his own consulting company for 10 years, primarily providing business and marketing strategy and scientific counsel to Fortune 500 companies. He worked for eight years in R&D, corporate finance and business strategy and development at Monsanto; as a senior consultant for Meyers, Norris, Penny focusing on commodity marketing, renewable energy, intellectual property protection, enterprise software applications, and scientific competitiveness; and most recently as the Business Development Manager at the Richardson Centre for Functional Foods & Nutraceuticals, Department of Food Science, University of Manitoba. He is also an adjunct faculty member in Dept. of Food Science.
Xiao Qiu is a Professor in the Department of Food and Bioproduct Sciences, University of Saskatchewan, Canada. He obtained his doctorate from the University of Guelph, Ontario, Canada. After graduation, he spent two years as Research Associate in the National Research Council of Canada, and seven years in the food industry first as Research Scientist and later as Research Director. In 2006, he joined the University of Saskatchewan as a faculty member to set up an institutional lipid biotechnology program. Since 2009, he has also been an Adjunct Research Officer in the National Research Council of Canada. His research interest covers plant and microbial lipids, and their biosynthesis and metabolic engineering in oilseed crops and oleaginous microorganisms.
Dr. Tom Warkentin is a Professor at the Crop Development Centre/Department of Plant Sciences, University of Saskatchewan. He received his Ph.D. in Crop Science from the University of Saskatchewan in 1992. He is breeding field pea cultivars with emphasis on agronomic traits (yield and lodging resistance), disease resistance (foliar and root diseases), and end-use quality (seed visual quality, seed coat durability, cooking quality, and nutritional quality including concentration of protein, starch, fiber, vitamins and minerals and their bioavailability). Tom is also involved in soybean breeding for the short season regions of western Canada with emphasis on high yield and early maturity.
Dr. Mutch is an Associate Professor in the Department of Human Health & Nutritional Sciences at the University of Guelph, Canada. He received his Ph.D. from the University of Lausanne Switzerland, and completed post-doctoral fellowships at The Scripps Research Institute in San Diego and the French National Institute for Health and Medical Research in Paris. Dr. Mutch leads a nutrigenomics research program that explores how fatty acid-gene interactions contribute to the development of obesity-related complications. His research focuses on the critical role of fatty acid desaturase (FADS) genes in the synthesis of omega-3 and omega-6 fats, and their influence on metabolic health. Dr. Mutch also investigates if FADS genes can be used to personalize omega-3 dietary habits to improve an individual’s health and well-being. Dr. Mutch is Editor-in-Chief of Lifestyle Genomics, and has published over 80 peer-reviewed articles in the field of nutrigenomics.
Dr. Steve Labrie is full professor at the Department of Food Sciences, Université Laval and a regular member of the STELA Dairy Research Center of the Institute on Nutrition and Functional Foods (INAF). He is a food microbiologist using the –omics approaches to study complex food microbial communities. Dr Labrie’s research focus mainly on understanding the food microbiome with the objective to optimize and improve the food quality and safety. He explored the dynamics of the cheese ecosystem in order to identify the beneficial and the deleterious species developing during ripening. Moreover he currently study the metabolism and the technological potential of "terroir" microbial strains to determine their role during the cheese making process.
David B. Levin is a Professor in the Department of Biosystems Engineering, at the University of Manitoba. Dr. Levin’s research is focused on “bioengineering for biofuels and bioproducts”, and integrates microbiology, biotechnology, and genome sciences with bioprocess and biosystems engineering. Dr. Levin was the co-Lead on the Genome Canada funded project on “Microbial genomics for biofuels and co-products from biorefining processes” with Dr. Richard Sparling (Department of Microbiology). Dr. Levin also led the Hydrogen Production and Purification theme of the NSERC funded Hydrogen Canada (H2CAN) network, and was the Prairie Platform leader within BioFuelNet, a pan-Canadian research network funded by the Network Centres of Excellence (NCE) program. He currently serves as the Academic lead on an Genome Canada funded Genome Applications Partnership Program (GAPP) called “Fibre composite and biometric genomics” (FiGoGen), focused on developing biocomposite materials with flax fibres and biodegradable resins derived from biodegradable biopolymers.
Dr. Barbara Stefanska is an Assistant Professor in Food, Nutrition and Health Program in the Faculty of Land and Food Systems at the University of British Columbia (UBC). She joined UBC in July 2017 from Purdue University, where she started her independent research path in nutritional sciences. Her area of expertise is nutritional epigenomics and cancer epigenetics. Dr. Stefanska completed a Master’s in public health and a PhD in biomedical sciences at Medical University of Lodz, Poland, followed by a postdoctoral training in the Department of Pharmacology and Therapeutics at McGill University in Montreal, Canada. During her doctoral and postdoctoral studies, Dr. Stefanska explored epigenetic effects of bioactive food components in cancer prevention and support of chemotherapy, and was the first who established the patterns of DNA methylation and gene expression in liver cancer patients and a functional role of DNA methylation differences observed between tumor and normal tissue. Her research determined a set of novel cancer candidate genes and potential diagnostic DNA methylation biomarkers. Epigenetic modifications play a significant role in normal development and genome stability and constitute a mechanism of genome adaptation to external stimuli.
Current research in Dr. Stefanska’s laboratory is focused on how diet can lead to health outcomes through modulating the epigenome and how the epigenome can serve as a readout of dietary exposures. Her research group investigates the link between bioactive food components, epigenetic alterations and carcinogenesis, including inflammation-driven cancer. A recent discovery by Stefanska’s group reports epigenetic mechanisms behind inhibition of the NOTCH oncogenic pathway in breast cancer upon exposure to polyphenols with stilbenoid structure. The results deliver a novel insight into epigenetic regulation of oncogenic signals in cancer and provide support for epigenetic-targeting strategies as an effective anticancer approach. Dr. Stefanska has published original research articles, reviews, commentaries, books and book chapters, and has given talks at national and international conferences. She serves on the editorial board of the British Journal of Pharmacology and is a member of the Prevention Group of the Alliance for Clinical Trials in Oncology.
Dr. Bouchard is associate professor of genetics and epigenetics at the Department of Biochemistry, Faculty of Medicine and Health Sciences, Université de Sherbrooke and head of the Department of Molecular Biology and Genetics at the university-affiliated Chicoutimi Hospital (QC, Canada). After Ph.D. studies in genetic epidemiology at Université Laval, he completed postdoctoral fellowships in transcriptomics (Dr. Marie-Claude Volh, CHU de Québec) and epigenomics (Dr. Arturas Petronis, University of Toronto). From 2008 to 2010, he was an Assistant Professor, Department of Medicine, Université de Montréal (QC, Canada).
Since 2009, he has been leading a research group dedicated to understand how epigenetic mechanisms are involved in the development of obesity, diabetes and cardiovascular disease. As a foundation of his research program, he contributed to build the ECO-21 and Gen3G Birth Cohorts, which included up to 1250 women recruited at the first trimester of pregnancy. The mothers and her child were then followed-up until 5 years postpartum. His current research projects aim to identify epigenetically-modified genes that play a causal role in fetal metabolic programming of childhood obesity as well as early epigenetic biomarkers for the development of gestational diabetes mellitus.
Vern Dolinsky is an Associate Professor at the University of Manitoba in the Department of Pharmacology and Research Scientist and Co-lead of the pediatric diabetes research theme (DREAM) at the Children’s Hospital Research Institute of Manitoba (CHRIM). He received his Master’s of Science at the University of Manitoba and his CIHR studentship-funded PhD at the University of Alberta. He completed post-doctoral fellowships at the University of Michigan and the University of Alberta.
Dr. Dolinsky’s research is focused on investigating the mechanisms involved in the development of gestational diabetes and how gestational diabetes contributes to the fetal programming of obesity, diabetes and related cardiovascular disorders in youth. His laboratory utilizes a combination of experimental animals, in vivo imaging as well as cellular molecular, biochemical, genomic and epigenomic approaches to expand the knowledge about the biological mechanisms that lead to obesity, diabetes and heart disease. This information aims to guide the development of novel therapies for obesity, diabetes and heart disease. Dr. Dolinsky’s lab is currently funded by two grants from the CIHR, the Heart and Stroke Foundation of Canada, Research Manitoba and the Canadian Foundation for Innovation. Dr. Dolinsky was recently awarded the Stewart Whitman-Amgen, the Ken Hughes Young Investigator Awards, Dr. John Moorhouse Research Fellow of the Diabetes Foundation of Manitoba and he is currently the Allen Rouse Basic Scientist of the Manitoba Medical Services Foundation.
Dr. Peter Eck, Associate Professor, Department of Human Nutritional Sciences at the University of Manitoba, investigates the impacts of genetic variations on health outcomes which are modifiable by lifestyle interventions. He discovered novel vitamin C transporters and associated their genetic variations with a variety of common and complex diseases. He also associated variations in various other nutrient membrane transporter genes with Inflammatory Bowel Diseases. He investigates the biological impact of disease associated genetic variations using molecular biology, cell biology and model organisms. Dr. Eck’s research aims to contribute to the development of personalized lifestyle interventions based on an individual’s genetic background.
Dr. Louis Pérusse is Professor and director of the Department of Kinesiology at the Faculty of Medicine in Laval University, Québec. He is a genetic epidemiologist with more than 20 years of research experience in the field of the genetics of complex diseases such as obesity, diabetes and cardiovascular diseases. Dr Pérusse is a member of the Institute of Nutraceutical and Functional Foods (INAF) of Laval University and past Editor-in-Chief of the Journal of Nutrigenetics and Nutrigenomics. He is the author of more than 500 papers and communications in the field of genetics of obesity and its related-metabolic complications and of adaptation to exercise training.
Marie-Claude Vohl completed her graduate studies at Laval University (1992-1997). She was interested in the genetics of dyslipidemia and obesity-related metabolic complications. In 1997-1998, she was enrolled in a post-doctoral fellow at the University of Ottawa Heart Institute where she studied antioxidant properties of HDL particles. During her second post-doctoral training (1998-1999) at McGill University in Montreal, she was interested in the genetics of complex diseases. She was appointed as a professor at the Department of Food Science and Nutrition at Laval University (Québec City) in 1999. Her research projects are aimed at the genetic/epigenetic dissection of the obesity-related metabolic complications. She is also interested in nutrigenetics/nutrigenomics and conducted different cross-sectional and clinical trials examining the combined effects of fish nutrients and genetic factors on cardiometabolic risk factors.
Since the beginning of her career, Professor Marie-Claude Vohl has published more than 240 peer-reviewed papers. She has been invited to give several presentations in national and international conferences. Her research programs are funded among others by CIHR, HSFC and NSERC. Since 2010, she is Canada Research Chair Tier 1 in Genomics Applied to Nutrition and Metabolic Health.
Olivia Dong is a registered dietitian, a licensed dietitian nutritionist in the state of North Carolina, and is currently a PhD candidate in the Center for Pharmacogenomics and Individualized Therapy at the UNC Eshelman School of Pharmacy. Her dissertation research focuses on the development of a new pharmacogenetic test, DNA2RxTM, which uses targeted next-generation sequencing technology. She is studying the pharmacoeconomic benefits of implementing this test for patients with coronary artery disease to help inform insurance reimbursement policies. An American Heart Association Pre-doctoral Fellowship supports her dissertation research. In addition, Olivia is integrating her training in nutrition and pharmaceutical sciences to develop the pharmaconutrigenetics field within precision medicine and has been invited to speak on this topic for various professional health groups in North Carolina.
Olivia has won multiple awards, including the Emerging Dietetic Leader Award from the Durham-Chapel Hill Dietetic Association and the Recognized Young Dietitian of the Year Award from the North Carolina Academy of Nutrition and Dietetics. In addition, she recently won a P.E.O. Scholar Award and was the recent recipient of the Kathryne A. Brewington Graduate Student Research Award, which is given annually to the most outstanding doctoral student in the UNC Eshelman School of Pharmacy.
Olivia completed her MPH from the UNC Gillings School of Global Public Health, her dietetics training from UNC Hospitals, and her BS in nutritional sciences, dietetics from UC Berkeley.
José M. Ordovás is Professor of Nutrition and Genetics at Tufts University and Senior Scientist at the USDA-Human Nutrition Research Center on Aging in Boston, where he also is the Director of the Nutrition and Genomics Laboratory. He is a Senior Scientist at IMDEA Alimentacion (Madrid, Spain). Dr. Ordovas was educated in Spain at the University of Zaragoza where he completed his undergraduate work in chemistry and received his PHD. He did postdoctoral work at MIT, and Harvard.
Dr. Ordovas’ research focuses on the genetic/epigenetic factors predisposing to cardiovascular disease and obesity and their interaction with the environment and behavioral factors with emphasis on diet. He has published about 800 scientific articles in peer review journals.
Throughout his career, Dr. Ordovas has received multiple honors for his scientific achievements including the USDA Secretary’s Award, the Danone Foundation Award, and the honorary degree in Medicine by the University of Cordoba in Spain. He is a Member of the Spanish Royal Academies of Sciences, Medicine, Nutrition and Pharmacy.
He serves on multiple editorial, advisory and peer review committees and he is a member of the Comité Científico y Técnico de la Agencia Estatal de Investigación (AEI) in Spain.
An associate professor in the Department of Food and Human Nutritional Sciences, at the University of Manitoba. Her research program includes studying the genetic disorder sitosterolemia.
Clinical Biochemist from Universidad de Concepción (Chile), Doctor in Molecular Informatics from the University of Cambridge (UK), with postdoctoral training in Bioengineering at University of California San Francisco (US). Daniel is currently the VP of research and development at uBiome Inc., where he leads several teams of computational chemists/biologists, bio– chem–informaticians, data curators and data engineers who are resolving important scientific and technical issues relating to: 1) Development of clinical microbiology diagnostic tests; 2) Functional/taxonomic annotation of proteins and genes; 3) Correlating taxa and metagenomic functions to different human health conditions. He also leads the scientific and clinical teams with which he has published 17 peer-reviewed scientific articles, as well as the intellectual property team with 120 patent applications sent to the United States Patent and Trademark Office (8 of which already have been authorized) and 60 international patented applications.
Daniel worked as an adjunct professor of bioinformatics at the Center for Bioinformatics and Integrative Biology at Universidad Andrés Bello in Santiago, Chile. There he leaded the enzyme informatics and phylogenomics lab which focuses on: 1) Characterizing the effect of mutations discovered in whole-exome sequences of tumors; 2) Re-engineering of enzymes and metabolic pathways for biotechnological applications; 3) Studying the evolution of function in superfamilies of proteins; 4) Functional annotation of genomes and metagenomes.
He is an active member of the International Society for Computational Biology where he served as program chair for the first Latin American regional meeting of the society, and currently serves as sponsoring faculty advisor for the Chilean regional student group (RSG) of the society.
Dr. Elena Comelli, PhD is an Associate Professor and holds the Lawson Family Chair in Microbiome Nutrition Research at the Department of Nutritional Sciences and the Joannah and Brian Lawson Centre for Child Nutrition, Faculty of Medicine, and University of Toronto. Since 2015, Dr Comelli is also Adjunct Professor at the Department of Kinesiology at Brock University. Dr Comelli graduated at the University of Milano, Italy, and then obtained her PhD from ETH, Zurich, Switzerland with a research on probiotics for oral health. Afterwards, she did a postdoc at the Scripps Research Institute in San Diego, USA, working in the field of glycomics. In 2003, Dr Comelli returned to Switzerland and worked as a project manager at Nestlé Research Centre in Lausanne. In 2007, she joined the University of Toronto and in 2014 she was named the Lawson Family Chair in Microbiome Nutrition Research. Dr Comelli’s group investigates the relationship between diet and the gut microbiome, including regulation of intestinal responses, such as via microRNA. The lab has a strong focus on early stages of life and nutritional programming of the gut microbiome for long-term health. Elena is also an Associate Editor for the journal Applied Physiology, Nutrition and Metabolism.
Peter J.H. Jones, Canada Research Chair in Functional Foods and Nutrition, joined University of Manitoba on Nov. 1, 2005, as Director of Richardson Centre for Functional Foods and Nutraceuticals. Dr. Jones was awarded Distinguished Professor in Human Nutritional Sciences, Agriculture and Foods Sciences, as well as Food Science, Agriculture & Food Sciences at the University of Manitoba in 2016. Dr. Jones main appointment is in the Department of Food Science with a cross-appointment in Human Nutritional Sciences.
A native of Vancouver, BC, Dr. Jones received a BSc degree in Biochemistry at the University of British Columbia. He obtained an MSc in Human Nutrition at the same institution before completing a PhD in Nutritional Biochemistry from the University of Toronto in 1985. After two years with the Clinical Nutrition Research Center at the University of Chicago as a Medical Research Council of Canada post-doctoral fellow, Dr. Jones spent several years on faculty with the Division of Human Nutrition at the University of British Columbia. Dr. Jones was Director of the School Dietetics and Human Nutrition at McGill University from 1994-99; in addition being a professor and holding a cross-appointment in the Dept. of Medicine until 2005.
Dr. Zhou received her PhD in Biology from University of Washington at Seattle in 2012. She recently finished her post-doctorate training with Dr. Michael Snyder at Stanford University. With Dr. Snyder, she studies Type 2 Diabetes (T2D), and utilizes multi-omic techniques to measure both host and microbial molecular changes over time and to understand underlying associations with the disease onset and development. Recently, Zhou and others published a controlled longitudinal weight perturbation study with intensive characterizations by multi-omics profiling to further understand the insulin resistance, which is an important factor in T2D development. Zhou has published papers in internationally reputable journals, such as Nature Biotechnology, Cell Stem Cell, Cell Systems, EMBO Journal and PNAS, and actively serves as a reviewer for a number of scientific journals in the genomics field.
Prof. Oliver Fiehn has pioneered developments and applications in metabolomics with over 220 publications to date, starting in 1998 as postdoctoral scholar and from 2000 onwards as group leader at the Max-Planck Institute for Molecular Plant Physiology in Potsdam, Germany. Since 2004 he is Professor at the UC Davis Genome Center, overseeing his research laboratory and the satellite core service laboratory in metabolomics research. Since 2012, he serves as Director of the NIH West Coast Metabolomics Center, supervising 35 staff operating 16 mass spectrometers and coordinating activities with three UC Davis satellite labs, including efforts for combined interpretation of genomics and metabolomics data. The West Coast Metabolomics Center provides the most extensive and most in-depth analysis of metabolites available today, using a range of validated protocols for fee-for-service projects and scientific collaborations.
Professor Fiehn’s research aims at understanding metabolism on a comprehensive level in human population cohorts, animal and plant models, and cells and microorganisms. In order to leverage data from these diverse sets of biological systems, his research laboratory focuses on standardizing metabolomic reports and establishing metabolomic databases and libraries, for example the MassBank of North America that hosts over 200,000 public metabolite mass spectra and BinBase, a resource of over 90,000 samples covering more than 1,900 studies. Professor Fiehn’s laboratory members develop and implement new approaches and technologies in analytical chemistry for covering the metabolome, from increasing peak capacity by ion mobility to compound identifications through cheminformatics workflows and software. He collaborates with a range of investigators for interpreting metabolomic data in human diseases through statistics, text mining and pathway-based mapping efforts. He also studies fundamental biochemical questions from metabolite damage repair to the new concept of epimetabolites, the chemical transformation of primary metabolites that gain regulatory functions in cells.
For his work, Professor Fiehn has received a range of awards including the 2014 Molecular & Cellular Proteomics Lecture Award and the 2014 Metabolomics Society Lifetime Achievement Award. He served on the Board of Directors of the Metabolomics Society from 2005-2010 and 2012-2015, organizing a range of workshops and conferences, including the 2011 Asilomar metabolomics meeting and the 2015 Metabolomics Society international conference in San Francisco that reached a record of over 1,000 participants.
Martin Kohlmeier, MD, PhD, after medical school and residency training, completed graduate studies in bioinformatics, clinical chemistry and laboratory medicine at Heidelberg University, at the Max-Planck-Institute for Nutrition Research in Dortmund, and later at the Free University in Berlin. He is professor of nutrition at the University of North Carolina at Chapel Hill, director of the Human Research Core and the nutrigenetics laboratory at the UNC Nutrition Research Institute in Kannapolis, fellow of Wolfson College at Cambridge University, UK, and president-elect of ISNN.
He investigates what inherited differences mean for nutrient metabolism and how genetic information can support better nutrition decisions. For translation of such insights into practice he has developed software that guides towards food choices tailored to individual needs and preferences (https://www.nutriscope.us, access code “in18”).
Current work focuses on precision nutrition for improving muscle performance, nutrient-gene interactions causing muscle loss with advancing age, and genetic variants responsible for differences in energy metabolism.
Dr. Ahmed El-Sohemy is a Full Professor at the University of Toronto and has held a Canada Research Chair in Nutrigenomics. He earned his PhD in Nutritional Sciences from the University of Toronto and completed a postdoctoral fellowship at Harvard. He returned to Toronto in 2000 to establish a research program in nutritional genomics. The goal of his research is to elucidate the genetic basis for variability in nutrient response on health and performance. Dr. El-Sohemy has published over 140 peer-reviewed articles and has given over 200 invited talks around the world. He is on the editorial board of 10 scientific and medical journals and served as an expert reviewer for more than 30 other journals and 12 granting agencies. He has over 5,300 citations with an H-index of 41. Dr. El-Sohemy has served on Health Canada’s Scientific Advisory Board and several international expert advisory panels. He has made numerous appearances on TV, radio and in print media, and was voted one of the top 10 people to watch in 2004 by the Toronto Star, Canada’s largest daily newspaper, and in 2007 was nominated for Canada’s Top 40 Under 40 award. In 2013, Dr. El-Sohemy was named one of the top 10 inventors of the year by UofT and the following year he was awarded the Centrum Foundation New Scientist Award for Outstanding Research by the Canadian Nutrition Society. Last year he was awarded the Mark Bieber Professional Award by the American College of Nutrition. He is the founder of Nutrigenomix Inc. and Chair’s the company’s International Science Advisory Board.
Susan Carnell received her BA in Experimental Psychology from the University of Oxford and her PhD in Health Psychology at University College London, and completed post-doctoral training at University College London and Columbia University. In 2013 she joined the Division of Child & Adolescent Psychiatry, Department of Psychiatry & Behavioral Sciences, Johns Hopkins School of Medicine, where she is an Assistant Professor. The central question motivating her research program is, "Why do some people become obese while others don't?” To address this she uses a range of methods including behavioral tests, self- and parent-report questionnaires, genotyping, hormonal assays, and neuroimaging techniques (fMRI, MRI, PET). Ongoing research projects include investigations of appetite and body weight in infants, children, adolescents and adults, including studies of bariatric surgery and anorexia nervosa.
Matthew Lange, PhD, is a Food Scientist and Informatician at UC Davis with over 20 years experience building data, information, and knowledge systems for academia, industry, and government operations. As the Principle Investigator for International Center for Food Ontology Operability Data and Semantics (IC-FOODS) at UC Davis, Dr. Lange leads efforts to build the semantic and distributed ledger infrastructure for the Internet of Food. The Semantic Web of Food (SWoF) and Internet of Food (IoF) hold promise to fundamentally alter the way we produce, process, deliver and consume food: giving rise to ecosystems of next-generation knowledge tools that lower technical innovation barriers for creation of novel, traceable, ecologically-friendly foods, products, medicines, and lifestyle regimens: precisely personalized for health and delight, and aggregatable for population and market analyses. The IoF holds potential to provide infrastructure enabling companies to compete to deliver healthier, more sustainable, and more trustworthy foods.
Dr. Silveira is an Assistant Professor in the Department of Psychiatry at McGill University, a researcher at the Douglas Mental Health University Institute (the Douglas Institute) and a Primary Investigator at the Ludmer Centre for Neuroinformatics & Mental Health.
Dr. Silveira’s research combines the Developmental Origins of Health & Disease (DOHaD) theory and the Life Course Theory (LCT), emerging fields of research that have significant implications for public health and illness prevention. Her research focuses on how perinatal and early-childhood environments can shape and modulate both health and disease across the lifespan, into old age. Her aim is to identify genetic/epigenetic markers that interact with environmental adversities in childhood, modifying behaviors (impulsivity, sensitivity to reward, food choices) that ultimately affect healthy growth and neurodevelopment, increasing an individual’s risk for developing chronic diseases and mental illnesses across their lifespan. The goal is to determine which combination of factors increases an individual’s risk for developing chronic diseases and mental illnesses across their lifespan.
Dr. Silveira’s research in human and non-human models also focuses on the interface between mental illnesses, altered metabolic states, and the resulting syndromes (e.g., visceral obesity, dyslipidemia, insulin resistance and hypertension). Such research may lead to evidence for the role of metabolic sates, such as insulin and insulin resistance, in mediating normal and abnormal brain function and the link to neuro-inflammation, which could lead to new treatments for neurological and psychiatric disorders.
A paediatrician and neuroscientist with extensive research, teaching and clinical experiences, Dr Silveira is ideally positioned to lead studies combining multiple and interconnected aspects of child health. In Brazil, Dr. Silveira led the Developmental Origins of Health & Disease (DOHaD) Porto Alegre group, which collaborated extensively with the Maternal Adversity, Vulnerability & Neurodevelopment (MAVAN) project, a Montreal-based longitudinal birth cohort initiated in 2003 at the Douglas Institute.
Dr. Silveira has published more than 80 peer-reviewed papers, with an h-index of 24 and some 1600 citations, she is one of the Ludmer Centre’s most promising researchers. Since 2014, Dr Silveira has been a multi-year recipient of research awards including the Lundbeck Prize, the Paulo Mathias Award, the Danone Prize, and the David Barker Prize, among others. She has also shown significant leadership in preparing tomorrow’s research leaders, supervising over 30 PhD and MSc students and mentoring several post-doctoral fellows.
Dr. Silveira obtained an MD (2001) and specialized in Paediatrics (2002-2006). She received a MSc (2004) and a PhD (2007) in Neurosciences from the Universidade Federal do Rio Grande do Sul (UFRGS), Brazil. She also completed a postdoctoral fellowship (2007–2009) in Dr Meaney´s Lab at the Douglas Institute. Before joining McGill and returning to the Douglas Institute in 2016, Dr Silveira was an Assistant Professor in the UFRGS Paediatrics Department (2009-2016) and led the externally funded lab, the DOHaD Porto Alegre group.
The Ludmer Centre is a transdisciplinary, multicentre, big-data approach to innovative research in normal brain development and disorders - research encompassing neurological disorders, from Alzheimer’s to Parkinson’s, and mental illnesses, from anxiety disorders to schizophrenia.
Dr. MacKay has a PhD in Human Nutritional Sciences and is an Assistant Professor in the Department of Community Health Sciences at the University of Manitoba. He is also a Clinical Trialist at the George and Fay Yee Centre for Healthcare Innovation. Dylan is a nutritional biochemist, specializing in human clinical trials and inter-individual variability. Dylan is also very interested in how to appropriately translate scientific findings to combat misinformation, especially on the internet and social media. Twitter: @dylanmackayphdFollow @dylanmackayphd
Timothy Caulfield is a Canada Research Chair in Health Law and Policy, a Professor in the Faculty of Law and the School of Public Health, and Research Director of the Health Law Institute at the University of Alberta. His interdisciplinary research on topics like stem cells, genetics, research ethics, the public representations of science and health policy issues has allowed him to publish over 350 academic articles. He has won numerous academic and writing awards and is a Fellow of the Royal Society of Canada, the Trudeau Foundation and the Canadian Academy of Health Sciences. He contributes frequently for the popular press and is the author of two national bestsellers: The Cure for Everything: Untangling the Twisted Messages about Health, Fitness and Happiness (Penguin 2012) and Is Gwyneth Paltrow Wrong About Everything?: When Celebrity Culture and Science Clash (Penguin 2015). Caulfield is also the host and co-producer of the documentary TV show, A User’s Guide to Cheating Death.
Justine Horne is a registered dietitian with the College of Dietitians of Ontario and sessional instructor at Western University (Brescia University College) in the Department of Food and Nutritional Sciences. She received her Master of Science in Food and Nutrition degree from Western University, and is currently pursuing her PhD in Health and Rehabilitation Sciences with funding obtained through a CIHR Doctoral Award. Justine’s research seeks to determine the impact of lifestyle genomic testing on weight management and body composition, as well as nutrition and physical activity habits, while using the Theory of Planned Behaviour as a methodological framework for her research. To conduct this research, Justine is leading The Nutrigenomics, Overweight/Obesity and Weight Management Trial (The NOW Trial) - a pragmatic, randomized controlled trial in two distinct patient populations.
Justine has received a number of awards and honours for her accomplishments including the Western Gold Medal, MScFN Leadership Award, Sir Wilfrid Laurier Memorial Prize (Western University) and a TalentEdge Internship in nutrigenomics from the Ontario Centres of Excellence. She is known in the dietetics community for her expertise in nutrigenomics and has been invited to present on the topic locally, nationally, and internationally to various healthcare professionals, university students, and academics. She is also an advocate for evidence-based health information and advice, and is the chair of the Professional Titles for Dietitians in Ontario Advocacy Group. Twitter: @justinehorneRDFollow